Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2013, Article ID 903094, 3 pages
Case Report

Cell Based Autologous Immune Enhancement Therapy (AIET) after Radiotherapy in a Locally Advanced Carcinoma of the Cervix

1Chennai Meenakshi Multispeciality Hospital Limited, New No. 72, Old No. 148, Luz Church Road, Mylapore, Chennai 600 004, India
2Dr. Kamakshi Memorial Hospital, 1 Radial Road, Pallikaranai, Chennai 600100, India
3Nichi-In Centre for Regenerative Medicine (NCRM), PB 1262, Nungambakkam, Chennai 600034, India
4Biotherapy Institute of Japan, No. 8, No. 4 Edagawa 2-chome, Koto-ku, Tokyo 135-0051, Japan
5Hope Foundation (Trust), B6, 13, Zakariah Colony III Street, Choolaimedu, Chennai 600094, India
6School of Medicine, Yamanashi University, 1110 Shimokato, Chuo, Yamanashi 409-3898, Japan
7The Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), PB 1262, Nungambakkam, Chennai, Tamil Nadu 600034, India

Received 16 February 2013; Accepted 19 March 2013

Academic Editors: K. Aogi, J. M. Buchanich, S. B. Chichareon, C. Gennatas, and F. A. Mauri

Copyright © 2013 Sumana Premkumar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Globocan 2008 cancer fact sheet,” 2013,
  2. L. Denny, “Cervical cancer: prevention and treatment,” Discovery Medicine, vol. 14, no. 75, pp. 125–131, 2012. View at Google Scholar
  3. T. Takayama, T. Sekine, M. Makuuchi et al., “Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial,” Lancet, vol. 356, no. 9232, pp. 802–807, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Kimura and Y. Yamaguchi, “A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma,” Cancer, vol. 80, no. 1, pp. 42–49, 1997. View at Google Scholar
  5. K. Kono, A. Takahashi, F. Ichihara et al., “Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial,” Clinical Cancer Research, vol. 8, no. 6, pp. 1767–1771, 2002. View at Google Scholar · View at Scopus
  6. S. Baskar, V. Dedeepiya, H. Terunuma et al., “Prolonged survival of a patient with inoperable, locally advanced adenocarcinoma of pancreas after autologous immune enhancement therapy (AIET) with chemotherapy,” Indian Journal of Cancer. In press.
  7. S. R. Manjunath, G. Ramanan, V. D. Dedeepiya et al., “Autologous immune enhancement therapy in recurrent ovarian cancer with metastases: a case report,” Case Reports in Oncology, vol. 5, no. 1, pp. 114–118, 2012. View at Google Scholar
  8. M. Takada, H. Terunuma, X. Deng et al., “Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach,” Breast Cancer, vol. 18, no. 1, pp. 64–67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. P. G. Rose, S. Ali, C. W. Whitney, R. Lanciano, and F. B. Stehman, “Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study,” Gynecologic Oncology, vol. 121, no. 3, pp. 542–545, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Houvenaeghel, L. Lelievre, A. L. Rigouard et al., “Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer,” Gynecologic Oncology, vol. 102, no. 1, pp. 74–79, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Polterauer, L. Hefler, V. Seebacher et al., “The impact of lymph node density on survival of cervical cancer patients,” British Journal of Cancer, vol. 103, no. 5, pp. 613–616, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Goto, N. Shirotani, M. Hatakeyama et al., “Clinical benefit of non-toxic therapy in patients with advanced cancer (opinion),” Anticancer Research, vol. 22, no. 4, pp. 2461–2464, 2002. View at Google Scholar · View at Scopus